For the next 5 year cycle of the Cancer Center Support Grant, the Kimmel Cancer Center is requesting Developmental Funds to foster collaborative research projects among KCC consortium cancer center members. During the past grant cycle, no developmental funds were available from the CCSG. However, through a combination of philanthropy, ARRA funding, and an American Cancer Society Institutional Research Grant, 60 projects were funded. These funds are a critical source of flexible funding for the KCC, and provide a vital source of support for new research opportunities through pilot project funding. In addition funds are requested to facilitate recruitment of new faculty. Center-wide recruitment needs have been identified in several areas: Translational Breast Cancer Research (BBC), Radiation Research (RRTB), Epigenetics in Cancer (MBG) and Molecular Epidemiology (Gl). The KCC Basic Science Advisory Committee will play a central role in determining which pilot projects requests will be funded. Therefore, it is important to note that the Committee which will be making the decision will include faculty from all the consortium partners (TJU, LIMR, Drexel), and faculty from all the consortium partners will be eligible to apply for pilot project funding. Members of the developing program in Population Science will be eligible to apply for pilot project funding under a somewhat altered process.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA056036-18
Application #
9282724
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
2017-06-01
Project End
2018-05-31
Budget Start
2017-06-01
Budget End
2018-05-31
Support Year
18
Fiscal Year
2017
Total Cost
$64,174
Indirect Cost
$22,301
Name
Thomas Jefferson University
Department
Type
Domestic Higher Education
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
McNair, Christopher; Xu, Kexin; Mandigo, Amy C et al. (2018) Differential impact of RB status on E2F1 reprogramming in human cancer. J Clin Invest 128:341-358
Garcia, Samantha A; Lebrun, Aurore; Kean, Rhonda B et al. (2018) Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant. J Neurovirol 24:606-615
Vido, Michael J; Le, Kaitlyn; Hartsough, Edward J et al. (2018) BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association. Cell Rep 25:1501-1510.e3
Brody, Jonathan R; Dixon, Dan A (2018) Complex HuR function in pancreatic cancer cells. Wiley Interdiscip Rev RNA 9:e1469
Liao, Lili; Liu, Zongzhi Z; Langbein, Lauren et al. (2018) Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer. Elife 7:
Heeke, Arielle L; Pishvaian, Michael J; Lynce, Filipa et al. (2018) Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types. JCO Precis Oncol 2018:
Parent, Kristin N; Schrad, Jason R; Cingolani, Gino (2018) Breaking Symmetry in Viral Icosahedral Capsids as Seen through the Lenses of X-ray Crystallography and Cryo-Electron Microscopy. Viruses 10:
Rappaport, Jeffrey A; Waldman, Scott A (2018) The Guanylate Cyclase C-cGMP Signaling Axis Opposes Intestinal Epithelial Injury and Neoplasia. Front Oncol 8:299
Pandya, Kalgi D; Palomo-Caturla, Isabel; Walker, Justin A et al. (2018) An Unmutated IgM Response to the Vi Polysaccharide of Salmonella Typhi Contributes to Protective Immunity in a Murine Model of Typhoid. J Immunol 200:4078-4084
Hussain, Maha; Daignault-Newton, Stephanie; Twardowski, Przemyslaw W et al. (2018) Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. J Clin Oncol 36:991-999

Showing the most recent 10 out of 807 publications